Construction and characterization of replication-competent simian immunodeficiency virus vectors that express gamma interferon

被引:38
作者
Giavedoni, LD [1 ]
Yilma, T [1 ]
机构
[1] UNIV CALIF DAVIS,DEPT VET PATHOL,INT LAB MOLEC BIOL TROP DIS AGENTS,DAVIS,CA 95616
关键词
D O I
10.1128/JVI.70.4.2247-2251.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We report the construction and characterization of several replication-competent simian immunodeficiency virus (SIV) vectors with a deletion in the viral nef gene (Sn-Delta nef that express gamma interferon (IFN-gamma). The expression of the cytokine gene was controlled either by the simian virus 40 early promoter or by the SIV 5' long terminal repeat regulatory sequences, utilizing the nef gene splice signals. To enhance the expression of IFN-gamma, the two in-frame nef start codons were mutated without altering the Env amino acid sequence (SIVHyIFN). Plasmids containing full-length proviral genomes were used to obtain high-titer stocks of each recombinant virus in cell cultures. Expression of IFN-gamma by STVHyIFN reached levels as high as 10(6) U/ml after 11 days in culture. The IFN-gamma gene was unstable and sustained deletions after serial passage of SIVDelta nef vectors in CEM-X-174 cells, The degree of instability appears to depend on size and orientation of the insert and the expression of IFN-gamma. Only one virus, SIVHyIFN, expressed detectable levels of IFN-gamma up to the sixth passage. Prospects for the use of IFN-gamma and other lymphokines to enhance the safety and efficacy of live attenuated vaccines are discussed.
引用
收藏
页码:2247 / 2251
页数:5
相关论文
共 32 条
  • [1] REDUCED VIRUS LOAD IN RHESUS MACAQUES IMMUNIZED WITH RECOMBINANT GP160 AND CHALLENGED WITH SIMIAN IMMUNODEFICIENCY VIRUS
    AHMAD, S
    LOHMAN, B
    MARTHAS, M
    GIAVEDONI, L
    ELAMAD, Z
    HAIGWOOD, NL
    SCANDELLA, CJ
    GARDNER, MB
    LUCIW, PA
    YILMA, T
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (02) : 195 - 204
  • [2] ANDERSON PK, 1988, J IMMUNOL, V40, P3599
  • [3] PATHOGENICITY OF LIVE, ATTENUATED SIV AFTER MUCOSAL INFECTION OF NEONATAL MACAQUES
    BABA, TW
    JEONG, YS
    PENNINCK, D
    BRONSON, R
    GREENE, MF
    RUPRECHT, RM
    [J]. SCIENCE, 1995, 267 (5205) : 1820 - 1825
  • [4] DISTINCT MODES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRAL LATENCY REVEALED BY SUPERINFECTION OF NONPRODUCTIVELY INFECTED CELL-LINES WITH RECOMBINANT LUCIFERASE-ENCODING VIRUSES
    CHEN, BK
    SAKSELA, K
    ANDINO, R
    BALTIMORE, D
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (02) : 654 - 660
  • [5] VPR IS REQUIRED FOR EFFICIENT REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN MONONUCLEAR PHAGOCYTES
    CONNOR, RI
    CHEN, BK
    CHOE, S
    LANDAU, NR
    [J]. VIROLOGY, 1995, 206 (02) : 935 - 944
  • [6] PROTECTIVE EFFECTS OF A LIVE ATTENUATED SIV VACCINE WITH A DELETION IN THE NEF GENE
    DANIEL, MD
    KIRCHHOFF, F
    CZAJAK, SC
    SEHGAL, PK
    DESROSIERS, RC
    [J]. SCIENCE, 1992, 258 (5090) : 1938 - 1941
  • [7] ANALYSIS OF HIV-1 ENVELOPE MUTANTS AND PSEUDOTYPING OF REPLICATION-DEFECTIVE HIV-1 VECTORS BY GENETIC COMPLEMENTATION
    DELWART, EL
    BUCHSCHACHER, GL
    FREED, EO
    PANGANIBAN, AT
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (09) : 1669 - 1677
  • [9] INTERFERON-GAMMA PROTECTS PRIMARY MONOCYTES AGAINST INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    FAN, SX
    TURPIN, JA
    ARONOVITZ, JR
    MELTZER, MS
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 56 (03) : 362 - 368
  • [10] PREVENTION OF VACCINIA VIRUS-INFECTION IN IMMUNODEFICIENT MICE BY VECTOR-DIRECTED IL-2 EXPRESSION
    FLEXNER, C
    HUGIN, A
    MOSS, B
    [J]. NATURE, 1987, 330 (6145) : 259 - 262